Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Añadir filtros








Intervalo de año
1.
Acta cir. bras ; 32(10): 862-872, Oct. 2017. graf
Artículo en Inglés | LILACS | ID: biblio-886174

RESUMEN

Abstract Purpose: To investigate whether the neuroprotective effect of TSA on cerebral ischemia reperfusion injury is mediated by the activation of Akt/GSK-3β signaling pathway. Methods: Mice were randomly divided into four groups (n=15): sham group (S); ischemia reperfusion group (IR); ischemia reperfusion and pretreated with TSA group (IR+T); ischemia reperfusion and pretreated with TSA and LY294002 group (IR+T+L). The model of cerebral ischemia reperfusion was established by 1h of MCAO following 24h of reperfusion. TSA (5mg/kg) was intraperitoneally given for 3 days before MCAO, Akt inhibitor, LY294002 (15 nmol/kg) was injected by tail vein 30 min before the MCAO. Results: TSA significantly increased the expression of p-Akt, p-GSK-3β proteins and the levels of SOD, Bcl-2, reduced the infarct volume and the levels of MDA, ROS, TNF-α, IL-1β, Bax, Caspase-3, TUNEL and attenuated neurological deficit in mice with transient MCAO, LY294002 weakened such effect of TSA dramatically. Conclusions: TSA could significantly decrease the neurological deficit and reduce the cerebral infarct volume, oxidative stress, inflammation, as well as apoptosis during cerebral ischemia reperfusion injury, which was achieved by activation of the Akt/GSK-3β signaling pathway.


Asunto(s)
Animales , Masculino , Ratas , Transducción de Señal/efectos de los fármacos , Ataque Isquémico Transitorio/metabolismo , Fármacos Neuroprotectores/farmacología , Glucógeno Sintasa Quinasa 3/efectos de los fármacos , Proteínas Proto-Oncogénicas c-akt/efectos de los fármacos , Inhibidores de Histona Desacetilasas/farmacología , Transducción de Señal/fisiología , Ataque Isquémico Transitorio/fisiopatología , Glucógeno Sintasa Quinasa 3/metabolismo , Modelos Animales de Enfermedad , Ratones Endogámicos BALB C
2.
Acta cir. bras ; 32(5): 376-387, May 2017. tab, graf
Artículo en Inglés | LILACS | ID: biblio-837712

RESUMEN

Abstract Purpose: To investigate whether modulating GSK-3β could attenuate myocardial ischemia reperfusion injury (MIRI) induced acute lung injury (ALI) and analyze the underlying mechanism. Methods: Male SD rats were subjected to MIRI with or without myocardial ischemic post-conditioning in the presence or absence of GSK-3β inhibitor. GSK-3β inhibitor was injected peritoneally 10min before MIRI. Lung W/D weight ratio, MPO, PMNs, histopathological changes, TUNEL, Bax, Bcl-2, IL-6, IL-8, IL-10, GSK-3β, and caspase-3 were evaluated in the lung tissues of all rats. Results: After MIRI, lung injury was significantly increased manifested as significant morphological changes and increased leukocytes in the interstitial capillaries, Lung W/D ratio, MPO, and PMN in BALF, which was associated with enhanced inflammation evidenced by increased expressions of IL-6, IL-8 and reduced expression of IL-10. MIRI significantly increased cell apoptosis in the lung as increased levels of apoptotosis, Bax, cleaved caspase-3, and reduced expression of Bcl-2 was observed, which was concomitant with reduced p-GSK-3β. All these changes were reversed/prevented by ischemic post-conditioning, while these beneficial effects of ischemic post-conditioning were abolished by GSK-3β inhibition. Conclusion: Myocardial ischemia reperfusion injury induces acute lung injury by induction of inflammation and cell apoptosis. Ischemic post-conditioning protects the lung from ALI following MIRI by increasing p-GSK-3β.


Asunto(s)
Animales , Masculino , Daño por Reperfusión Miocárdica/prevención & control , Sustancias Protectoras/metabolismo , Lesión Pulmonar Aguda/prevención & control , Poscondicionamiento Isquémico/métodos , Glucógeno Sintasa Quinasa 3 beta/metabolismo , Distribución Aleatoria , Regulación hacia Abajo , Interleucinas/metabolismo , Ratas Sprague-Dawley , Apoptosis/efectos de los fármacos , Peroxidasa/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Sustancias Protectoras/farmacología , Etiquetado Corte-Fin in Situ , Modelos Animales , Activación Enzimática , Proteína X Asociada a bcl-2/metabolismo , Caspasa 3/metabolismo , Lesión Pulmonar Aguda/enzimología , Glucógeno Sintasa Quinasa 3 beta/antagonistas & inhibidores , Glucógeno Sintasa Quinasa 3 beta/farmacología , Inflamación/metabolismo , Infarto del Miocardio/patología , Neutrófilos/enzimología
3.
Arq. neuropsiquiatr ; 73(4): 342-349, 04/2015. tab, graf
Artículo en Inglés | LILACS | ID: lil-745750

RESUMEN

Many studies of protein expression after traumatic brain injury (TBI) have identified biomarkers for diagnosing or determining the prognosis of TBI. In this study, we searched for additional protein markers of TBI using a fluid perfusion impact device to model TBI in S-D rats. Two-dimensional gel electrophoresis and mass spectrometry were used to identify differentially expressed proteins. After proteomic analysis, we detected 405 and 371 protein spots within a pH range of 3-10 from sham-treated and contused brain cortex, respectively. Eighty protein spots were differentially expressed in the two groups and 20 of these proteins were identified. This study validated the established biomarkers of TBI and identified potential biomarkers that could be examined in future work.


Muitos estudos de expressão proteica após lesão cerebral traumática (LCT) identificam biomarcadores para determinação diagnóstica ou prognóstica do LCT. No presente estudo, foram investigados marcadores proteicos adicionais de LCT, através de um aparelho de impacto no fluxo e perfusão em ratos S-D. Eletroforese bidimensional em gel e espectrometria de massa foram utilizadas para identificar diferentes proteínas expressas. Após a análise proteômica, detectamos marcas de proteínas 405 e 371, com pH variando entre 3-10 no córtex de ratos sham e naqueles com contusão cerebral, respectivamente. Oitenta marcas proteicas foram expressas nos dois grupos e 20 destas proteínas foram identificadas. Este estudo validou o estabelecimento de biomarcadores de LCT e identificou potencial biomarcadores que poderão ser estudados em estudos futuros.


Asunto(s)
Animales , Masculino , Biomarcadores/análisis , Lesiones Encefálicas/diagnóstico , Corteza Cerebral/química , Proteómica , Química Encefálica , Lesiones Encefálicas/metabolismo , Modelos Animales de Enfermedad , Electroforesis en Gel Bidimensional , Espectrometría de Masas , Pronóstico , Distribución Aleatoria , Ratas Sprague-Dawley , Valores de Referencia , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA